Navigation Links
Oridion Announces Significant Medical Research to be Presented at AARC Congress

JERUSALEM and NEEDHAM, Massachusetts, December 10 /PRNewswire-FirstCall/ -- Oridion Systems Ltd. (SIX Swiss Exchange: ORIDN) today announced that three substantial medical research project findings will be presented at the upcoming AARC (American Association for Respiratory Care) Congress in Anaheim, California. These studies confirm the clinical benefits of End-tidal CO2 (EtCO2) monitoring using Oridion Microstream(R) capnography technology and clearly show that capnography needs to be included in a hospital's respiratory monitoring strategy.

Proprietary EtCO2 monitoring solutions from Oridion can increase patient safety and improve patient outcomes utilizing information from the patient's respiratory system. Oridion has focused on providing a technology that provides the clinician with a simple and accurate assessment of a patient's ventilatory status which can provide an early prediction of events. A short summary of the studies from ASA and AARC are discussed below.

An Israel Institute of Technology - Technion study concluded that EtCO2 measurement contributes significantly to the prediction of events during pediatric and adult endoscopy procedures under general anesthesia and conscious sedation.

Two research studies, completed in cooperation between The Brigham and Women's Hospital (Boston, MA) and The University of Alabama in Birmingham, investigated the use of Oridion Microstream Technology and the Smart CapnoLine(R) H Plus CO2 sampling line during the administration of supplemental oxygen delivered by a wide range of oxygen masks. These masks blow oxygen enriched breathing gas toward the patient's nose and mouth. Patients receiving oxygen are at risk for breathing difficulty which can be best monitored by measuring ventilation, which is measured by capnography. In these studies, the Oridion products revealed no significant difference in EtCO2 or respiratory rate when the test subjects were breathing with and without the oxygen masks for all masks and oxygen concentrations tested. The researchers believe that this will aid patient monitoring in clinical practice.

The above medical research projects join four additional papers that were presented in October 2008 at the ASA (American Society of Anesthesiologists) Annual Meeting in Orlando, Florida. Among the studies released was a comprehensive research paper focused on Oridion's latest major initiative "IPI* - Integrated Pulmonary Index" conducted by physician/scientists from Medical College of Georgia in Augusta. IPI helps caregivers manage four complicated monitoring parameters with a single, simplified number. IPI utilizes End-tidal CO2, respiration rate, heart rate and SpO2 to provide an uncomplicated, inclusive assessment of a patient's ventilatory status.

Additional papers presented at ASA included a study from the Brigham & Women's Hospital in Boston showing that CO2 measurement using the Oridion CapnoBloc(TM) is an effective and accurate sampling method during upper gastrointestinal endoscopy. Another important study concluded that expert medical education and training can improve patient safety.

Furthermore, a study published in this month's issue of PEDIATRICS - The Official Journal of the American Academy of Pediatrics concluded that Microstream(R) capnography with its low flow rate made non-invasive capnography possible in the NICU. The study also showed that ETCO2, measured by Microstream(R) capnography has good correlation with PACO2, and is reliable in severe lung disease.

A full list of the medical publications can be found on the Oridion Website research.html

(Due to the length of this URL, it may be necessary to copy and paste this hyperlink into your Internet browser's URL address field. Remove the space if one exists.)

Oridion is the global leader of innovative capnography monitoring solutions helping to improve patient safety, and its Microstream(R) capnography technology has become the standard of care in ventilation monitoring.

*IPI is pending FDA 510(k) clearance

About Oridion

Oridion Systems Ltd. ( is a global medical device company specializing in patient safety monitoring. The Company operates through wholly owned subsidiaries in the United States, Europe, and Israel.

Oridion develops proprietary medical devices and patient interfaces, based on its patented Microstream(R) technologies, for the enhancement of patient safety through the monitoring of the carbon dioxide (CO2) in a patient's breath. These products provide effective, proven airway management and are used in various clinical environments, including procedural sedation, pain management, operating rooms, critical care units, post-anesthesia care units, emergency medical services, transport, alternate care and other settings where patients' ventilation may be compromised and at risk.

    For further Oridion information please contact:

    Gerry Feldman, President,
    Walter Tabachnik, Chief Financial Officer,
    Elena Gerberg, Investor Relations,
    phone: +972-2-589-9159,
    address: Oridion Systems Ltd., P.O. Box 45025, 91450 Jerusalem, Israel.

SOURCE Oridion Systems Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Oridion Signs Agreement With Major US Health Plan Provider for Microstream(R) Capnography
2. Oridion Expands its OEM Partnerships - New Agreement with Spacelabs Healthcare
3. Oridion Wins 2008 Manufacturers Partnership Award From Independent Medical Distributors Association
4. Oridion Launches its Fully Integrated Remote Monitoring System and SARA Software for Improved Patient Safety
5. Proteolix Announces Positive Data From Two Ongoing Phase 2 Clinical Trials of Carfilzomib in Multiple Myeloma at the 50th Annual Meeting of the American Society of Hematology
6. Nile Therapeutics Announces Positive Results from Phase 1b Safety and Pharmacodynamics Study of CD-NP in Patients with Heart Failure
7. Omeros Announces Results from a Phase 1 Study of OMS201 for Use During Urological Surgery
8. Environmental Tectonics Corporation Announces Placement of Two Monoplace Chambers at St. John Wound Center; First Computer-controlled Hyperbaric Chambers in Oklahoma
9. Genomic Health Announces Appointment of Ginger Graham to Board of Directors
10. Human Genome Sciences Announces Albuferon(R) Meets Primary Endpoint in Phase 3 Trial in Chronic Hepatitis C
11. Elsevier Announces Winners of 3rd Annual Scopus Young Indian Scientist Award
Post Your Comments:
(Date:11/30/2015)... , December 1, 2015 Partnership includes an ... for the u niversity , ... support treatment s cale - up ... (ARVs)   Africa , where licensees based anywhere in the ... on SDN technology. --> Africa , where licensees based anywhere ...
(Date:11/30/2015)... Mass. , Nov. 30, 2015 ... HART ), a biotechnology company developing bioengineered organ ... received written notification from The NASDAQ Stock Market ... bid price requirements. The letter noted that as ... HART,s common stock having exceeded $1.00 per share ...
(Date:11/30/2015)... BETHESDA, Md. , Nov. 30, 2015 /PRNewswire/ ... property development company committed to the fostering and ... on the current and prospective initiatives designed to ... , Chief Executive Officer of Spherix. "Based on ... potential future licensees exceeds $50 billion and Spherix ...
(Date:11/30/2015)... 30, 2015  Champions Oncology, Inc. (CSBR), engaged in ... personalize the development and use of oncology drugs, today ... will be presenting at the LD MICRO Investor Conference ... Time (PST).  The conference, held at the Luxe Sunset ... , will feature 200 small/micro-cap companies and is ...
Breaking Biology Technology:
(Date:11/19/2015)... , Nov. 19, 2015  Based on its ... & Sullivan recognizes BIO-key with the 2015 Global Frost ... year, Frost & Sullivan presents this award to the ... catering to the needs of the market it serves. ... line meets and expands on customer base demands, the ...
(Date:11/18/2015)... 2015  As new scientific discoveries deepen our understanding ... healthcare providers face challenges in better using that knowledge ... addition, as more children continue to survive pediatric cancer, ... old age. John M. Maris, M.D ., ... Philadelphia (CHOP) . --> John M. ...
(Date:11/17/2015)... Paris from 17 th until ... from 17 th until 19 th November ... has invented the first combined scanner in the world which scans ... Until now two different scanners were required: one for passports ... on the same surface. This innovation is an ideal solution ...
Breaking Biology News(10 mins):